Pomegra
Onos Health closed a $17M Series A led by Costanoa to bring AI to behavioral therapy notes, helping insurers like Aetna track care quality in real time.
Key Takeaways
- Costanoa Ventures led the $17M round, joined by Flare Capital Partners and strategic investor CVS Health Ventures.
- More than 70% of behavioral health quality signals are buried in free-text notes that legacy payer systems cannot read.
- Aetna is already live on the platform; total company funding now stands at $23.5M following a $6.3M seed in October 2025.
Lead
Onos Health announced a $17 million Series A on August 26, 2026, to scale an AI platform that parses unstructured therapy notes and clinical documentation for commercial health insurers. Costanoa Ventures led the round, with Flare Capital Partners and CVS Health Ventures participating. The San Francisco company, founded in 2024 by former Bain consultants, has now raised $23.5 million in total since its $6.3 million seed eleven months ago.
What Problem Is Onos Solving?
The core issue is that behavioral health produces an outsized share of free-text records. More than 70% of behavioral health quality signals sit in non-standardized documentation - therapy session notes, intake assessments, utilization histories - that legacy payer systems cannot parse. Structured claims data, which health plans have relied on for decades, misses most of what actually happens in a therapist's office.
Onos builds natural language processing tools that read this material on behalf of the insurer, then surface patterns about care quality, treatment gaps, and provider performance. The workflow replaces manual chart review by medical directors and quality teams, a process that is both slow and expensive at payer scale.
How Does It Work for Payers?
Health plans pay Onos to connect its platform to documentation received from behavioral providers. The system ingests the notes, runs quality checks against clinical guidelines, and flags outliers - providers whose care patterns deviate from norms, or members whose treatment appears to stall. Aetna, a subsidiary of CVS Health, is among the commercial insurers already live on the platform.
The participation of CVS Health Ventures alongside Aetna as a paying client is notable. Strategic investors in health tech rounds typically want early access to technology that could eventually migrate onto their own systems. CVS's dual role here suggests Onos is already embedded in at least part of the CVS Health ecosystem, which spans Aetna, Caremark, and the MinuteClinic network.
Prior Authorization in the Crosshairs
Federal pressure on health insurers to reduce behavioral health prior authorizations has intensified over the past two years, following CMS rule changes affecting Medicare Advantage plans. The tools Onos is building - specifically, AI that can verify whether delivered care matches clinical guidelines - could give payers a defensible alternative to blunt authorization controls.
That framing matters commercially and politically. Regulators and state attorneys general have made prior authorization in mental health a visible target. Payers need to demonstrate they monitor care quality without creating barriers to access. An AI layer that automates the evidence trail carries operational and regulatory appeal simultaneously.
Costanoa Ventures, the lead investor, focuses on enterprise software and data-intensive startups. Its investment fits a recognizable thesis: find industries with large volumes of messy unstructured data and back the infrastructure that renders it queryable. Flare Capital Partners, which invests specifically in health care technology, rounds out a syndicate heavy on sector expertise.
What Comes Next for Onos?
The company has said it plans to expand beyond commercial insurance into Medicare Advantage and Medicaid programs. Both segments carry distinct contractual and regulatory requirements. Medicaid in particular varies by state, so the build-out is not a simple replication of the Aetna model.
Onos also faces challenges standard to any company selling AI quality tools into large payer organizations. Integration timelines are long, procurement committees are large, and health plan IT environments are rarely uniform. The $17 million will need to fund a substantial sales and implementation operation alongside continued AI development.
Total disclosed funding of $23.5 million gives the company roughly 18 to 24 months of runway at a typical Series A burn rate - enough time to close several more health plan contracts and generate the outcome data a Series B investor would require.
Outlook
Onos Health is making a specific bet: that health insurers will pay for AI that reads clinical notes rather than just claims data, and that behavioral health is the right starting point. The $17 million round, backed by a credible mix of enterprise VC and strategic payer capital, gives the company the resources to test that thesis at scale. How behavioral health contract economics hold up under expansion into Medicare Advantage and Medicaid - where reimbursement dynamics differ sharply from commercial plans - will be the clearest signal of whether the model is durable.
